Vitrolife's CEO Thomas Axelsson has today sold 50,000 shares worth SEK 9.45 million. The remaining number of shares amounts to 50,500 shares.
"The Vitrolife share has developed very positively since I acquired the shares in 2012 and I therefore choose to realize part of the profit for private financial reasons," says Thomas Axelsson, CEO of Vitrolife AB. The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.
Gothenburg, February 11, 2020
VITROLIFE AB (publ)
Thomas Axelsson, CEO
This information was distributed by Cision http://www.cisionwire.se/